KORUST successfully concluded its participation in Arab Health 2025, one of the world’s largest medical device exhibitions, held in Dubai from January 27 to 30. During the event, the company achieved significant milestones in its global market expansion. Celebrating its 49th anniversary this year, Arab Health attracted more than 100,000 healthcare professionals and industry leaders from around the world. Compared to its participation five years ago, KORUST saw a notable increase in brand recognition, along with a substantial rise in inquiries and engagement from international visitors.

In particular, the respiratory care system CAREWAY emerged as a powerful alternative in a market previously dominated by major global brand. The product drew strong interest from distributors across the Middle East and Asia, generating numerous inquiries regarding exclusive partnership opportunities.

Despite the highly competitive medical aesthetics market, the UTIMS lineup—powered by KORUST’s patented Centerless technology—captured the attention of companies from Iran and Türkiye through its clear technological differentiation. In addition, GINOXELL, a stem cell booster, and RHINOS, an ENT medical device, secured on-site sample orders and initiated discussions for new distribution partnerships in key markets, including Saudi Arabia.

Beyond product promotion, the exhibition also served as a strategic platform for KORUST to gain deeper insights into regional regulatory developments and market pricing trends. Building on the strengthened global network and positive market feedback received during the event, KORUST plans to accelerate the finalization of export contracts and further diversify its international sales channels.